Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
World's 1st Stem Cell Book on Animals, Reveals How to Extend the Lives of Pets 2024-12-16 22:00
Perennial General Hospital Tianjin, China's First Wholly Foreign-Owned Private Tertiary General Hospital Will Soon Commence Operations 2024-12-16 19:37
HiRO Forges Strategic Partnership with CHA University Bundang Medical Center in South Korea 2024-12-16 10:30
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China 2024-12-16 07:55
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs 2024-12-15 13:30
Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024 2024-12-13 10:35
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS 2024-12-13 08:00
Heranova to Unveil HerResolve™, a Revolutionary Non-Invasive Endometriosis Test, at the Ovarian Club Asian Conference in Hong Kong 2024-12-13 08:00
2024 SABCS｜Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis 2024-12-13 07:20
DID YOU HAVE A HIP, KNEE, OR OTHER JOINT REPLACEMENT? 2024-12-12 23:19
Xinhua Silk Road: Pien Tze Huang boosts TCM globalization 2024-12-12 20:43
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer 2024-12-12 18:07
CBC Group R-Bridge Healthcare Fund Announces up to US$50 Million Financing for Human Investments Ltd. to Fund Motiva® Market Expansion 2024-12-12 14:14
Everest Medicines Announces the First Prescription of VELSIPITY® Issued in Macau, Officially Beginning to Benefit Asian Patients 2024-12-12 11:48
GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its pioneering Phase 3 Drug Nelonemdaz™ 2024-12-11 23:15
Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion 2024-12-11 14:44
Call for Application for 2025 Tsinghua Amgen Scholars Program 2024-12-11 14:33
Partnership Established to Advance WHO's Road Map for Neglected Tropical Diseases 2021-2030 2024-12-11 09:00
Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months 2024-12-10 22:31
Live from ASH 2024 | Ascentage Pharma Releases Updated Data of Bcl-2 Inhibitor Lisaftoclax in MDS that Demonstrates Potential Clinical Benefits and Favorable Safety 2024-12-10 22:20
1 2 3 4 5 537